Wearables

This channel includes news and new technology innovations for wearable cardiac diagnostic systems. These include technologies related to smart phone apps, wearable monitors, consumer-grade wearables and medical grade FDA cleared wearables. A good overview on the future of these technologies can be found in this article.

Remote cardiac monitoring vendor RhythMedix released its next-generation RhythmStar wearable device with built-in 4G cellular connectivity. The cardiac telemetry monitor can be worn for extended remote monitoring without the need for an additional phone or communication device. 

Remote cardiac monitoring vendor RhythMedix released its next-generation RhythmStar wearable device with built-in 4G cellular connectivity. The cardiac telemetry monitor can be worn for extended remote monitoring without the need for an additional phone or communication device. 

News | Wearables | February 23, 2021
February 23, 2021 — Remote cardiac monitoring vendor RhythMedix released its next-generation RhythmStar wearable device...
Two examples of hand-held, point-of-care-ultrasound (POCUS) being used to get immediate medical imaging information from patients in underserved areas. Left, a Butterfly Network system using an probe and an app turns a smartphone into an ultrasound system to image a patient at a remote African clinic. Right, a GE vScan being used to image patients in a rural community in Indian as part of an American Society of Echocardiography (ASE) outreach program.

Two examples of hand-held, point-of-care-ultrasound (POCUS) being used to get immediate medical imaging information from patients in underserved areas. Left, a Butterfly Network system using a probe and an app turns a smartphone into an ultrasound system to image a patient at a remote African clinic. Right, a GE vScan being used to image patients in a rural community in Indian as part of an American Society of Echocardiography (ASE) outreach program.

Feature | February 11, 2021 | By Dave Fornell, Editor
There is a lot of talk about health disparities between the insured vs. uninsured, low-income vs. higher-income, rural...
The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location.

The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location. 

News | EP Lab | February 02, 2021
February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current...
There has been an increasing trend in cardiology to use longer term remote monitoring wearable ECG tracking devices. This is an example of of the Cardiac Insight Cardea Solo adhesive patch device.

There has been an increasing trend in cardiology to use longer term remote monitoring wearable ECG tracking devices. This is an example of of the Cardiac Insight Cardea Solo adhesive patch device.

News | ECG | February 02, 2021
February 2, 2021 — Cardiac Insight, Inc. a healthcare company specializing in wearable cardiac sensors and automated...
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office visit. Floyd Russak, M.D., of Russak Personalized Medicine, an internal medicine physician practicing in Greenwood Village, Colo., manages many cardiac patients who do not have ready access to a cardiologist
Feature | Wearables | December 15, 2020
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office...
The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

The U.S. Food and Drug Administration (FDA) has cleared AliveCor's Kardia AI V2 next generation of interpretive artificial intelligence (AI)-based personal electrocardiogram (ECG) algorithms.

News | Artificial Intelligence | November 24, 2020
November 24, 2020 — The U.S. Food and Drug Administration (FDA) has cleared AliveCor's next generation of interpretive...
Videos | Atrial Fibrillation | November 18, 2020
Steven Lubitz, M.D., MPH, cardiac electrophysiologist, Massachusetts General Hospital, presented the late-breaking...
The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study evaluated the detection of silent, or previously undiagnosed, atrial fibrillation (AF) in moderate-risk individuals using the FDA-cleared Zio by iRhythm ambulatory monitoring patch. The results support the clinical value of early screening and targeted detection in moderate-risk populations. #AHA #AHA20 #AHA2020

The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study evaluated the detection of silent, or previously undiagnosed, atrial fibrillation (AF) in moderate-risk individuals using the FDA-cleared Zio by iRhythm ambulatory monitoring patch. The results support the clinical value of early screening and targeted detection in moderate-risk populations.

News | Atrial Fibrillation | November 16, 2020
November 16, 2020 — The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study...
Cardiac monitoring devices range from (left to right) the 12-lead ECG, Holter monitor, patch with snap fasteners, and patch with integrated electronics.

Cardiac monitoring devices range from (left to right) the 12-lead ECG, Holter monitor, patch with snap fasteners, and patch with integrated electronics.

News | Wearables | September 30, 2020
September 30, 2020 — In today’s digital age, focus on digital health and the quantified self have led to the rapid rise...
The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study (Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients). It will evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 

The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study to evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 

News | Wearables | September 25, 2020
September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the...
Fitbit Sense is the company’s first device compatible with an ECG app that enables users to take a spot check reading of their heart that can be analyzed for the heart rhythm irregularity atrial fibrillation (AFib).

Fitbit Sense is the company’s first device compatible with an ECG app that enables users to take a spot check reading of their heart that can be analyzed for the heart rhythm irregularity atrial fibrillation (AFib).

News | Wearables | September 24, 2020
September 24, 2020 — Fitbit received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as...
Selfied might be used with AI to identify patients with heart disease. Getty Images

Getty Images

News | Artificial Intelligence | August 24, 2020
August 24, 2020 — Sending a photo selfie to the doctor could be a cheap and simple way of detecting heart disease using...
Wearable Sensors and AI App Used to Remotely Monitor Heart Failure Patients in NorthShore Health System. Carnegie Mellon University, Northshore and physIQ launch Study of monitoring technology for high-risk cardiac and surgical patients.
News | Remote Monitoring | August 05, 2020
August 5, 2020 – NorthShore University HealthSystem , Carnegie Mellon University and physIQ are collaborating on a...
A team from Purdue University developed self-powered wearable triboelectric nanogenerators with polyvinyl alcohol-based contact layers for monitoring cardiovascular health.

A team from Purdue University developed self-powered wearable triboelectric nanogenerators with polyvinyl alcohol-based contact layers for monitoring cardiovascular health.

News | Wearables | July 22, 2020
July 22, 2020 — A team from Purdue University has developed self-powered wearable triboelectric nanogenerators (TENGs)...
VitalSight is a HIPAA-compliant, Medicare-reimbursable home blood pressure monitoring solution that generally comes at no cost to the patient, depending on their coverage. The kit typically includes a digital blood pressure monitor with cuff, weight scale and digital medication tracker, as well as a data hub.
News | Hypertension | July 15, 2020
July 15, 2020 – Omron Healthcare Inc. and Mount Sinai Health System, New York City’s largest academic medical system,...